CoQ10, Fibromyalgia, Eating Disorders, and the Importance of Hematological Screening

By

CoQ10 cannot regenerate dead or permanently scarred tissue. 
However, it helps protect and support existing cells by enhancing energy production (ATP) and reducing oxidative stress caused by free radicals. By improving mitochondrial function, CoQ10 supports the body's natural repair and healing processes.

Key Cellular and Tissue Benefits

1. Cellular Energy Production

  • CoQ10 plays a critical role in the mitochondrial electron transport chain.
  • It helps generate ATP, the primary energy source required for cell growth, division, maintenance, and repair.

2. Antioxidant Protection

  • CoQ10 acts as a powerful antioxidant that neutralizes harmful free radicals.
  • It also helps regenerate other antioxidants, including Vitamins C and E.
  • This protection helps preserve cellular components such as DNA, proteins, and cell membranes from oxidative damage.

3. Tissue Repair and Regeneration

  • Research, including periodontal health studies, suggests that CoQ10 supports fibroblast activity.
  • Fibroblasts are responsible for collagen production, which is essential for wound healing and tissue regeneration.
  • As a result, CoQ10 may help accelerate recovery of both soft and hard tissues following injury.

4. Mitochondrial Health and Healthy Aging

  • CoQ10 supports mitochondrial efficiency and may help counteract cellular aging (senescence).
  • By improving cellular metabolism, it may help protect against age-related tissue degeneration and functional decline.

CoQ10, Fibromyalgia, and Eating Disorders

Recent research on fibromyalgia and eating disorders has increasingly focused on oxidative stress and mitochondrial dysfunction as potential contributors to symptoms and disease progression.

Patients with fibromyalgia have frequently been found to exhibit reduced levels of CoQ10, leading researchers to investigate supplementation as a supportive strategy for improving cellular energy metabolism and reducing oxidative stress. Similar disturbances in mitochondrial function and energy metabolism have also been reported in individuals with eating disorders, where nutritional deficiencies and metabolic adaptations may further impair cellular function.

Because of these findings, CoQ10 supplementation is sometimes considered as part of a broader supportive treatment plan aimed at enhancing mitochondrial performance and reducing oxidative damage. However, the evidence remains evolving, and treatment decisions should be individualized.

The Importance of Hematological Evaluation

While many studies examining fibromyalgia and eating disorders focus primarily on metabolic, nutritional, or psychological factors, potential underlying hematological conditions are often overlooked. This represents a significant gap in clinical assessment.

One important example involves abnormalities of the blood-clotting protein von Willebrand factor (VWF). VWF plays a central role in platelet adhesion and blood coagulation. Disorders involving VWF, including Von Willebrand disease, are among the most common inherited bleeding disorders yet remain frequently underdiagnosed.

Symptoms associated with VWF abnormalities can overlap with those seen in complex multisystem conditions and may coexist with other clotting or bleeding risks that require careful evaluation and management.

CoQ10 and Coagulation Considerations

Before recommending supplements such as CoQ10, it is prudent to consider a patient's coagulation status.

  • CoQ10 shares structural similarities with vitamin K.
  • It may influence coagulation pathways in susceptible individuals.
  • Particular caution may be warranted in patients with known clotting disorders or those receiving anticoagulant therapy.

Although clinically significant coagulation effects are not observed in most individuals taking CoQ10, underlying bleeding or clotting disorders should still be considered as part of a comprehensive risk assessment.

Unfortunately, VWF testing and related coagulation studies are frequently omitted, especially when patients are primarily being treated for eating disorders, chronic pain syndromes, or fatigue-related conditions.

Failing to evaluate hematological factors may result in:

  • Incomplete diagnostic assessment.
  • Missed bleeding or clotting disorders.
  • Less individualized treatment decisions.
  • Potentially avoidable safety concerns when initiating supplementation.

Assessing CoQ10 Deficiency

Because CoQ10 is essential for mitochondrial energy production, deficiency may be investigated through a combination of biochemical, tissue-based, and genetic testing.

1. Biomarkers of Mitochondrial Dysfunction

Lactic Acid (Plasma)

  • Elevated plasma lactate levels can indicate impaired cellular energy production.
  • This may suggest underlying mitochondrial dysfunction, which is sometimes associated with CoQ10 deficiency.

Creatine Kinase (CK)

  • CK is an enzyme released when muscle tissue is damaged or inflamed.
  • Elevated CK levels are commonly seen in some forms of CoQ10 deficiency, particularly those involving muscle weakness or myopathy.

2. Direct Measurement of CoQ10 Levels

Plasma or Serum CoQ10

  • Blood CoQ10 levels can be measured, but results may be influenced by recent dietary intake and lipid concentrations.
  • For this reason, plasma levels do not always accurately reflect tissue CoQ10 status.

White Blood Cell Testing

  • Measuring CoQ10 in lymphocytes or platelets is often more informative than plasma testing.
  • These cellular measurements tend to correlate better with tissue CoQ10 concentrations.

Muscle Biopsy

  • Historically considered the diagnostic gold standard.
  • A tissue sample is analyzed for mitochondrial respiratory chain function and directly measured for CoQ10 content.
  • Although highly informative, it is invasive and typically reserved for selected cases.

3. Genetic Testing (Most Definitive for Primary Deficiency)

Because CoQ10 deficiency can arise from genetic causes or secondary factors such as medication use, molecular genetic testing is often used to establish a definitive diagnosis.

Gene Panels

  • Next-generation sequencing (NGS) panels can identify mutations in genes involved in CoQ10 biosynthesis, including:
    • COQ2
    • COQ4
    • COQ7
    • PDSS2

Why Genetic Testing Matters

  • It helps distinguish a primary (genetic) CoQ10 deficiency from secondary deficiencies caused by medications, metabolic disorders, or other health conditions.
  • This distinction can influence both prognosis and treatment strategies.

A More Comprehensive Clinical Approach

A responsible and individualized approach to patients with fibromyalgia, eating disorders, chronic fatigue, unexplained pain, or suspected mitochondrial dysfunction should extend beyond metabolic assessment alone.

Such an evaluation may include:

  • Assessment of oxidative stress and mitochondrial function.
  • Nutritional and metabolic screening.
  • CoQ10 status testing when clinically indicated.
  • Screening for coagulation abnormalities, including VWF-related disorders.
  • Review of medications that may affect coagulation or mitochondrial function.
  • Consideration of genetic testing when a primary CoQ10 deficiency is suspected.

Integrating hematological evaluation into the management of fibromyalgia and eating disorders may improve diagnostic accuracy, support more personalized care, and help ensure that supplementation strategies are implemented as safely and effectively as possible.

Bottom Line

CoQ10 cannot restore tissue that is dead or irreversibly scarred, but it can support cellular energy production, reduce oxidative damage, promote collagen synthesis, and improve mitochondrial function. While CoQ10 supplementation may be beneficial in selected patients with fibromyalgia, eating disorders, or mitochondrial dysfunction, these conditions often require broader evaluation. Screening for coagulation abnormalities—including VWF-related disorders—alongside metabolic and genetic assessment may provide a more complete understanding of a patient's health status and support safer, more individualized treatment decisions.

References:

Primary Coenzyme Q10 Deficiency Overview
https://www.ncbi.nlm.nih.gov/books/NBK410087/

 Hereditary Coenzyme Q Deficiency Syndromes - Ubiquinone Deficiency 
https://arupconsult.com/content/coenzyme-q-deficiency-syndromes

Coenzyme Q10 supplementation – In ageing and disease
https://www.sciencedirect.com/science/article/pii/S0047637421000932

Cellular Consequences of Coenzyme Q10 Deficiency in Neurodegeneration of the Retina and Brain https://pmc.ncbi.nlm.nih.gov/articles/PMC7730520/

Coenzyme Q10: Clinical Applications beyond Cardiovascular Diseases https://pmc.ncbi.nlm.nih.gov/articles/PMC8156424/

Fibromyalgia, Eating Disorders and Rehabilitation: The Nrf2 Link

https://www.mdpi.com/2076-3921/15/3/364

© 2000-2030 Sieglinde W. Alexander. All writings by Sieglinde W. Alexander have a fife year copy right. Library of Congress Card Number: LCN 00-192742 ISBN: 0-9703195-0-9 

Comments

Post a Comment

Popular posts from this blog

Schnitzler Syndrome: A Rare Autoinflammatory Disorder

By
Schnitzler syndrome is a rare, chronic autoinflammatory disease characterized by chronic urticaria (hives), recurrent fever, joint pain, and monoclonal gammopathy (abnormal proteins in the blood). First described by Dr. Liliane Schnitzler in 1972 , this condition is often misdiagnosed, leading to years of untreated symptoms before a correct diagnosis is made. The case report, " A 58-Year-Old Woman With Urticaria, Fever, and Joint Pain " , describes a case that closely aligns with my own experience with this challenging disorder. Key Features of Schnitzler Syndrome Schnitzler syndrome presents with a characteristic set of symptoms, though not all patients experience them in the same way: Chronic Urticaria (Hives) – Persistent, non-itchy or mildly itchy red patches that do not respond to antihistamines. Monoclonal Gammopathy (IgM or IgG type) – Abnormal monoclonal immunoglobulin detected in the blood (most commonly IgM ). Recurrent Fever – Unexplained fever episodes, often...
Read more

Acute Flaccid Myelitis (AFM): Understanding the “Polio-like” Illness Affecting the Spinal Cord

By
Acute flaccid myelitis (AFM) is a rare but serious neurological disorder that primarily affects children and results in sudden weakness or paralysis in the limbs. Often referred to as a “polio-like” illness, AFM has drawn growing attention over the past decade due to its similarities with poliomyelitis and its seasonal spikes in reported cases. While AFM remains uncommon, its potential severity—and the uncertainty surrounding its causes—make it an important condition for clinicians, parents, and public health officials to understand. What Is Acute Flaccid Myelitis? AFM is a condition that affects the gray matter of the spinal cord , where it damages motor neurons responsible for muscle movement. This leads to acute, flaccid paralysis , meaning muscles become limp and weak, often without warning. The condition can progress rapidly, and in some cases, the weakness can become long-lasting or even permanent. Although its symptoms resemble those of poliovirus infection, AFM is not cau...
Read more

Dysferlin Protein: Key Roles, Genetic Locations

By
Image
The purpose of this article is to share and discuss the details of a new discovery, which is highlighted within: CRISPR-Cas9: A Breakthrough Tool to Repair the DYSF Gene The dysferlin protein plays an essential role in maintaining the integrity of muscle cell membranes, particularly in tissues that endure significant mechanical stress, such as skeletal and cardiac muscles . Encoded by the DYSF gene , dysferlin is indispensable for repairing damaged cell membranes after injury caused by muscle contraction or external forces. This article explores the main locations where dysferlin is produced, its role in muscle repair, and supportive nutritional and therapeutic strategies for individuals with dysferlin deficiency, such as those affected by dysferlinopathies (e.g., Limb-Girdle Muscular Dystrophy Type 2B or Miyoshi Myopathy). Currently, there is no definitive answer as to why the severity of dysferlin protein expression or depletion varies. Do pathogens play a role in the methylation o...
Read more

Very Long-Chain Fatty Acids (VLCFAs) X-ALD and Spinal Muscular Atrophy (SMA): Exploring the Connection

By
Image
Introduction: White Brain Matter, VLCFAs, and X-ALD X-linked Adrenoleukodystrophy (X-ALD) is a rare inherited metabolic disorder and a major cause of progressive neurodegeneration in children—sometimes referred to as “childhood dementia.” Across related conditions, prevalence can range from approximately 1 in 2,000 to 1 in 500,000 newborns. Among its forms, childhood cerebral X-ALD is the most severe, marked by rapid inflammatory demyelination in the brain and often fatal outcomes if not treated early. At the core of X-ALD is a disruption in the metabolism of Very Long-Chain Fatty Acids (VLCFAs). Normally, these fatty acids are broken down in peroxisomes—specialized structures within cells that help maintain metabolic balance. In X-ALD, a mutation in the ABCD1 gene impairs this function, causing VLCFAs to accumulate, particularly in the white matter of the brain, spinal cord, and adrenal glands. This accumulation leads to demyelination, adrenal insufficiency (Addison’s disease), an...
Read more

Toxic Skin Condition Post-mRNA COVID-19 Vaccination

By
Image
Important update: My experiences have now been formally verified following several years of dismissal. Vasculitis syndromes: the pathogenic roles of COVID-19 and related vaccinations https://link.springer.com/article/10.1186/s12985-025-03032-x  ----------------------------------------- Identifying Severe Skin Conditions Post-Vaccination Following administration of the BioNTech mRNA vaccine, a small subset of individuals may develop severe and complex reactions. These reactions are often misdiagnosed or misunderstood due to their rarity and diverse presentation. This essay examines a case characterized by severe skin conditions, systemic symptoms, and complications such as hypercalcemia and crystal formation. It highlights the need for accurate diagnosis, holistic management, and increased awareness of these rare but significant vaccine-related adverse events. Initial Symptoms and Misdiagnoses Severe symptoms began shortly after the first dose of the BioNTech vaccine, initially pres...
Read more

Is ME CFS connected to Spinal Muscular Atrophy (SMA) or Post Polio?

By
Today, I understand why Spinal Muscular Atrophy (SMA) received little attention, particularly in the mid-50s. This complex and debilitating genetic illness was poorly understood, and patients' symptoms were often minimized or even dismissed. For more information, please visit the Spinal Muscular Atrophy (SMA) page on MalaCards . Even now, many neurologists lack detailed knowledge of SMA, and comprehensive examinations mentioned in research are rarely pursued. In 2008, while investigating permanent adrenal insufficiency, an MRI ordered by my endocrinologist unexpectedly revealed Chiari Malformation II. However, surgery in 2009 brought no improvement. In 2010, a DNA test showed a genetic marker in the ACTN3 gene: https://www.malacards.org/search/results?q=ACTN3%20gene%20and%20Spinal%20Muscular%20Atrophy%20(SMA) A 2015 MRI revealed ankylosing spondylitis, multiple Tarlov cysts, stenosis at L4 and L5, spinal canal narrowing, and widespread degenerative changes. Surgery on L4 and L5 ...
Read more

Polio and Post-Polio Syndrome (PPS): Summary and Key Insights

By
Image
  In the human body, poliovirus can survive and replicate for varying durations depending on the phase of infection and the individual's immune response: Incubation Period : After entering the body, poliovirus can begin replicating in the throat and intestines within a few hours. The typical incubation period lasts 7 to 10 days (but can range from 3 to 35 days ), during which the virus is actively multiplying. Shedding in Feces : Even after symptoms have resolved or in asymptomatic cases, poliovirus can be excreted in the feces for an extended period. In most individuals, the virus is shed in feces for 4 to 8 weeks after infection. In rare cases, especially in individuals with compromised immune systems, the virus may persist in the gut and be shed for months or even years (a condition called chronic excretion ). Bloodstream : If the virus enters the bloodstream and causes viremia, it may persist there for a few days before being cleared by the immune system or progressing to ...
Read more

Cytokine Storm, Mast Cell Activation Syndrome (MCAS), Endothelial Dysfunction and microclots/thrombosis?

By
Update: New Research Builds on Previous Findings Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2832234?utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamanetworkopen&utm_content=wklyforyou&utm_term=040925&adv= Conclusions: This recent cohort study builds upon earlier work by identifying COVID-related cytokine storm (COVID-CS) through common inflammation markers and comparing it with two other cytokine storm (CS) conditions: malignancy-associated hemophagocytic lymphohistiocytosis (MN-HLH) and CAR-T–associated cytokine release syndrome (CAR-T CRS) . Among the three groups, patients treated with CAR-T therapy showed the highest survival rates , in contrast to those with COVID-CS and MN-HLH. Interestingly, the study found that CAR-T CRS and COVID-CS share similar cytokine activation pathways , suggesting a comparable immune response mechanism. In c...
Read more

Introduction to Adenosine and Tachycardia

By
What is Adenosine? Adenosine is a chemical found in human cells, existing in three forms: adenosine, adenosine monophosphate (AMP), and adenosine triphosphate (ATP). Adenosine is a chemical found in the body that plays many roles, including influencing heart rate and promoting sleep and relaxation. It is also used as a medication to manage certain types of tachycardia, particularly supraventricular tachycardia. Adenosine works by slowing the heart rate through its action on the cardiac tissue. Adenosine production in the body occurs through multiple pathways: Phosphorylation of Adenine: Adenine can be directly phosphorylated to form AMP (adenosine monophosphate), which is then converted to ATP, ADP, and finally adenosine through dephosphorylation reactions. Breakdown of ATP: Adenosine is primarily formed in the body through the breakdown of ATP, which releases energy. ATP can be dephosphorylated stepwise through the action of various enzymes: ATP is first converted to ADP (adeno...
Read more

The Impact of Acids on Muscular and Vascular Systems: Potential Negative Outcomes

By
This is ongoing research, and updates will be included as soon as they become available. Acids, whether from external sources (like industrial chemicals) or internal imbalances (such as metabolic disorders), can have profound effects on both the muscular and vascular systems.   Exposure to strong acids or acid imbalances in the body can disrupt cellular function, cause tissue damage, and lead to systemic health problems. This article explores how acids can negatively impact muscular and vascular health, with an emphasis on both external exposure to corrosive acids and internal acid imbalances caused by metabolic disorders or genetic conditions. Since not everyone is affected by ME/CFS or COVID, it could be beneficial to test for genetic predispositions, such as amino acids, particularly fatty acids. 1. External Acid Exposure and Its Effects on Muscular and Vascular Systems 1.1. Muscular Effects Muscle tissue is highly sensitive to changes in pH, and exposure to strong acids ca...
Read more